We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

ADVANCED INSTRUMENTS

Advanced Instruments designs, manufactures and markets laboratory products for the clinical, food and dairy, microbio... read more Featured Products: More products

Download Mobile App





Advanced Instruments Introduces New Automated Osmometer at AACC 2022

By LabMedica International staff writers
Posted on 27 Jul 2022

A new osmometer delivers the automation and data management capabilities modern clinical labs require to free up tech time, improve result turnaround times, reduce errors, and ensure effortless compliance. More...

Advanced Instruments, LLC (Norwood, MA, USA) announced the newest addition to its clinical line of freezing point osmometers, the OsmoPRO MAX Automated Osmometer, at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo. The OsmoPRO MAX has been designed for clinical laboratories of all sizes seeking higher productivity through automation. The instrument's innovative flow-through technology eliminates manual pipetting and consumables, allowing testing to begin with the push of a button.

The OsmoPRO MAX goes beyond providing accurate and precise test results to deliver a fully automated solution. It uses the industry-preferred freezing point depression method to provide reliable results in minutes. The instrument provides increased efficiency and a simplified osmolality testing workflow:

  • Direct sampling from primary tubes eliminates the need for sample cups.
  • Continuous loading of samples in their primary tubes as they arrive minimizes workflow interruptions and eliminates batch testing.
  • Ready-to-use system fluid automates cleaning between samples for up to 500 tests.
  • Automated barcode scanning reduces transcription errors and prevents sample mix-ups.
  • Automatic data upload capability to the AdvancedQC peer group program facilitates monitoring of quality control trends and instrument performance.

"The OsmoPRO MAX delivers the ease of use, automation, and data management features today's clinical laboratories seek," said Byron Selman, CEO of Advanced Instruments. "Advanced Instruments continues to innovate in the field of osmometry while remaining committed to the product quality and reliability that our customers have depended on for the past 65 years."

Related Links:
Advanced Instruments, LLC 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.